{"matchedTerms": [], "ambiguousTerms": [{"searchTerm": "5605", "geneName": "MAP2K2", "geneLongName": "MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2", "entrezId": 5605, "geneCategories": [{"id": "4c14ec3171544bd2b18b2f1a45e6c8f2", "name": "KINASE"}, {"id": "25da529a29714d34bc2e75f0856e1f63", "name": "SERINE THREONINE KINASE"}, {"id": "6c528ef943614261afc5e4f52a3c60ee", "name": "TYROSINE KINASE"}, {"id": "655bedfa9d71482796a5a34b87dfb297", "name": "DRUG RESISTANCE"}, {"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}, {"id": "0d157beb-fd17-404d-8755-3a81aa5ed704", "name": "CLINICALLY ACTIONABLE"}], "interactions": [{"interactionId": "0600f378-33fa-49dd-918f-6a160c676108", "interactionTypes": [], "drugName": "CHEMBL546797", "drugConceptId": "chembl:CHEMBL546797", "sources": ["DTC"], "pmids": [], "score": 0.05}, {"interactionId": "7a5aa09e-7b46-4e22-a629-67a1a0f5d28c", "interactionTypes": [], "drugName": "VANDETANIB", "drugConceptId": "chembl:CHEMBL24828", "sources": ["DTC"], "pmids": [], "score": 0.03}, {"interactionId": "67fb6d8e-db0d-4c73-972c-57c160366cb5", "interactionTypes": ["inhibitor"], "drugName": "SELUMETINIB", "drugConceptId": "chembl:CHEMBL1614701", "sources": ["TALC", "MyCancerGenome", "ClearityFoundationClinicalTrial", "ChemblInteractions", "MyCancerGenomeClinicalTrial", "TTD"], "pmids": [17332304, 28029918, 17699718], "score": 0.4}, {"interactionId": "8aa755e6-8e40-451e-b24d-34a50328350d", "interactionTypes": [], "drugName": "CEDIRANIB", "drugConceptId": "chembl:CHEMBL491473", "sources": ["DTC"], "pmids": [], "score": 0.03}, {"interactionId": "54a8c2ea-c151-4ef0-a74c-dc0e4b41a3c3", "interactionTypes": ["inhibitor"], "drugName": "TRAMETINIB DIMETHYL SULFOXIDE", "drugConceptId": "chembl:CHEMBL2105741", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.77}, {"interactionId": "c30fab6c-c805-4e58-91c9-b096ffa32cf0", "interactionTypes": [], "drugName": "VEMURAFENIB", "drugConceptId": "chembl:CHEMBL1229517", "sources": ["CIViC"], "pmids": [24265153], "score": 0.11}, {"interactionId": "8684ef7c-d4d0-4fe4-a4f9-13e9d5be0f6f", "interactionTypes": [], "drugName": "ARRY-300", "drugConceptId": "chembl:CHEMBL3545359", "sources": ["TdgClinicalTrial"], "pmids": [], "score": 0.52}, {"interactionId": "c1839315-1a97-44a1-937d-a5ac9c8c4d0e", "interactionTypes": ["inhibitor"], "drugName": "AS-703988", "drugConceptId": "chembl:CHEMBL3545243", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.77}, {"interactionId": "82f40f9f-8346-4cc9-bf8d-b7942f484cfe", "interactionTypes": ["inhibitor"], "drugName": "BALAMAPIMOD", "drugConceptId": "chembl:CHEMBL2104954", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.77}, {"interactionId": "ff9b5356-3d92-4443-96b7-78f791892e15", "interactionTypes": [], "drugName": "CHEMBL406845", "drugConceptId": "chembl:CHEMBL406845", "sources": ["DTC"], "pmids": [], "score": 0.06}, {"interactionId": "37434d6e-c591-44e3-8639-570c608bd688", "interactionTypes": ["inhibitor"], "drugName": "RG-7167", "drugConceptId": "chembl:CHEMBL3545383", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.77}, {"interactionId": "90f52207-be38-4cf4-9f37-b4969112c6a7", "interactionTypes": ["allosteric modulator", "inhibitor"], "drugName": "COBIMETINIB", "drugConceptId": "chembl:CHEMBL2146883", "sources": ["MyCancerGenome", "ClearityFoundationClinicalTrial", "ChemblInteractions", "MyCancerGenomeClinicalTrial", "OncoKB"], "pmids": [], "score": 0.55}, {"interactionId": "444cce2f-7418-40c2-aef1-8c25b277f95f", "interactionTypes": ["antagonist", "inhibitor"], "drugName": "TRAMETINIB", "drugConceptId": "chembl:CHEMBL2103875", "sources": ["TALC", "MyCancerGenome", "ClearityFoundationClinicalTrial", "CIViC", "MyCancerGenomeClinicalTrial"], "pmids": [25452114, 23432625], "score": 0.26}, {"interactionId": "149efcfa-1ff2-427e-a5f7-bec11585a47f", "interactionTypes": [], "drugName": "ILORASERTIB", "drugConceptId": "chembl:CHEMBL1980297", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "21cd822e-3e8e-4ac4-a329-8d79f729f1f5", "interactionTypes": [], "drugName": "RG-1530", "drugConceptId": "chembl:CHEMBL1980391", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "0fe5923a-a79b-418a-b376-b885bcf22e1a", "interactionTypes": ["allosteric modulator", "inhibitor"], "drugName": "BINIMETINIB", "drugConceptId": "chembl:CHEMBL3187723", "sources": ["MyCancerGenome", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "ChemblInteractions", "MyCancerGenomeClinicalTrial"], "pmids": [28587477], "score": 0.52}, {"interactionId": "dc284602-2f57-45c9-be4f-7ead1ab91e9b", "interactionTypes": [], "drugName": "CHEMBL1956073", "drugConceptId": "chembl:CHEMBL1956073", "sources": ["DTC"], "pmids": [20053779], "score": 1.55}, {"interactionId": "42d57bab-049d-4746-8a61-46cdf0eb01db", "interactionTypes": ["inhibitor"], "drugName": "COBIMETINIB FUMARATE", "drugConceptId": "chembl:CHEMBL2364607", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.77}, {"interactionId": "e574ae39-6256-45e5-8a6d-595679ac2290", "interactionTypes": [], "drugName": "PF-00562271", "drugConceptId": "chembl:CHEMBL1084546", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "77473145-57f4-483e-bcc2-6ea440fa6d1d", "interactionTypes": ["allosteric modulator", "inhibitor"], "drugName": "REFAMETINIB", "drugConceptId": "chembl:CHEMBL1236682", "sources": ["MyCancerGenome", "ChemblInteractions"], "pmids": [], "score": 0.44}, {"interactionId": "f932a8af-bbb5-40a6-bb84-97dc9c28d8b5", "interactionTypes": ["inhibitor"], "drugName": "TAK-733", "drugConceptId": "chembl:CHEMBL1615025", "sources": ["MyCancerGenome", "ClearityFoundationClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.58}, {"interactionId": "52871910-c71a-414a-859d-7cbeec41fe6e", "interactionTypes": ["inhibitor"], "drugName": "RG-7420", "drugConceptId": "chembl:CHEMBL3330650", "sources": ["MyCancerGenome"], "pmids": [], "score": 0.39}, {"interactionId": "2da9fd1d-16cb-4edd-a26c-d3bcf4818657", "interactionTypes": [], "drugName": "CENISERTIB", "drugConceptId": "chembl:CHEMBL1967878", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "a1ffb1c7-ba83-4888-9501-2daa213b8631", "interactionTypes": ["inhibitor"], "drugName": "RO-4987655", "drugConceptId": "chembl:CHEMBL1614766", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.22}, {"interactionId": "08bffbce-ba57-4e1f-98ca-175c9f409770", "interactionTypes": ["inhibitor"], "drugName": "WX-554", "drugConceptId": "chembl:CHEMBL3545145", "sources": ["TdgClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.44}, {"interactionId": "d9f2d202-d3c2-4503-b108-c1f344b880f6", "interactionTypes": ["inhibitor"], "drugName": "PIMASERTIB", "drugConceptId": "chembl:CHEMBL2107832", "sources": ["TALC", "MyCancerGenome", "ClearityFoundationClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.69}, {"interactionId": "becef6d1-5b7d-4848-bb05-30fce3ec81f1", "interactionTypes": ["inhibitor"], "drugName": "CI-1040", "drugConceptId": "chembl:CHEMBL105442", "sources": ["MyCancerGenome", "ChemblInteractions"], "pmids": [], "score": 0.13}, {"interactionId": "6b3248b7-e3a6-4f18-8bbe-88af6823ef72", "interactionTypes": [], "drugName": "TOZASERTIB", "drugConceptId": "chembl:CHEMBL572878", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "c91892be-3dd5-462c-beab-42d2ade74cb5", "interactionTypes": [], "drugName": "CHEMBL202721", "drugConceptId": "chembl:CHEMBL202721", "sources": ["DTC"], "pmids": [], "score": 0.09}, {"interactionId": "424674c1-e61d-45c1-a3d7-5a5c29bf8def", "interactionTypes": [], "drugName": "TAE-684", "drugConceptId": "chembl:CHEMBL509032", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "f3f49353-ea19-4bef-96b8-0988b165e4bc", "interactionTypes": [], "drugName": "PD-0166285", "drugConceptId": "chembl:CHEMBL49120", "sources": ["DTC"], "pmids": [], "score": 0.03}, {"interactionId": "513fbd14-4cdd-47ee-9604-8aa841b100cd", "interactionTypes": ["inhibitor"], "drugName": "AZD-8330", "drugConceptId": "chembl:CHEMBL3182621", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.77}, {"interactionId": "d5b91361-867f-4014-8f22-f1f90351acde", "interactionTypes": [], "drugName": "CHEMBL379975", "drugConceptId": "chembl:CHEMBL379975", "sources": ["DTC"], "pmids": [], "score": 0.04}, {"interactionId": "04493b3c-e9f0-4b26-a156-04f8808975e0", "interactionTypes": [], "drugName": "JNJ-7706621", "drugConceptId": "chembl:CHEMBL191003", "sources": ["DTC"], "pmids": [], "score": 0.03}, {"interactionId": "d1438457-cd6a-4c1b-8132-8243d6abb520", "interactionTypes": ["inhibitor"], "drugName": "RG-7304", "drugConceptId": "chembl:CHEMBL3545081", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.77}, {"interactionId": "59140b88-05e0-4d97-9c6e-ac0cc04eae2d", "interactionTypes": [], "drugName": "DABRAFENIB", "drugConceptId": "chembl:CHEMBL2028663", "sources": ["CIViC"], "pmids": [24265153, 25452114], "score": 0.24}, {"interactionId": "187beb95-79a6-441f-aa0a-d5fa99321e67", "interactionTypes": ["inhibitor"], "drugName": "PD-0325901", "drugConceptId": "chembl:CHEMBL507361", "sources": ["DTC", "MyCancerGenome", "ChemblInteractions"], "pmids": [23398453], "score": 0.56}, {"interactionId": "8d46e32d-b67a-4860-bb21-af005006f68f", "interactionTypes": [], "drugName": "DASATINIB", "drugConceptId": "chembl:CHEMBL1421", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "7db0d022-9f31-4154-8978-8d7c42bc952e", "interactionTypes": [], "drugName": "DOVITINIB", "drugConceptId": "chembl:CHEMBL522892", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "21a26e3a-b0e3-4b94-9bf2-8fa59f6ae351", "interactionTypes": [], "drugName": "LINIFANIB", "drugConceptId": "chembl:CHEMBL223360", "sources": ["DTC"], "pmids": [], "score": 0.02}]}, {"searchTerm": "5605", "geneName": "IGHV3-47", "geneLongName": "IMMUNOGLOBULIN HEAVY VARIABLE 3-47 (PSEUDOGENE)", "entrezId": 28425, "geneCategories": [], "interactions": []}], "unmatchedTerms": []}